Filter announcements
Loading...
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model…
Gland Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 25, 2026. Further, the company has informed the Exchange regarding voting results.
Gland Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 25, 2026
Gland Pharma Limited has informed the Exchange regarding Appointment of Mr Deepak Sapra as Chief Executive Officer of the company w.e.f. November 16, 2026.
Gland Pharma Limited has informed the Exchange about Copy of Newspaper Publication
Gland Pharma Limited has informed the Exchange about Copy of Newspaper Publication